Skip to main content
Tiziana Life Sciences Ltd logo

Tiziana Life Sciences Ltd — Investor Relations & Filings

Ticker · TLSA ISIN · BMG889121031 LEI · 984500769407C5E46F42 US Professional, scientific and technical activities
Open in API
Filings indexed 460 across all filing types
Latest filing 2020-12-17 Regulatory Filings
Country BM Bermuda
Listing US TLSA

About Tiziana Life Sciences Ltd

https://www.tizianalifesciences.com/

Tiziana Life Sciences Ltd. is a clinical-stage biotechnology company focused on developing innovative immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's core strategy involves utilizing alternative drug delivery routes, such as intranasal administration, to modulate the immune system. Its lead clinical candidate, foralumab (TZLS-401), is the only fully human anti-CD3 monoclonal antibody being investigated for neurological conditions. Foralumab is in clinical development for the treatment of Non-Active Secondary Progressive Multiple Sclerosis (na-SPMS), Alzheimer's disease, Amyotrophic Lateral Sclerosis (ALS), and Multiple System Atrophy (MSA). The company's pipeline also includes an anti-IL-6 receptor monoclonal antibody (TZLS-501) for potential application in lung diseases.

Recent filings

Filing Released Lang Actions
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It references an attached Regulatory News Service (RNS) announcement about the proposed admission to the Main Market and cancellation of trading on AIM. The document itself is short (2967 characters) and primarily serves to furnish the RNS announcement rather than containing substantive financial data or detailed report content. According to the 'Menu vs Meal' rule, such a document that provides an announcement or notification rather than the full report should be classified as a Regulatory Filing (RNS).
2020-12-17 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It references a Regulatory News Service (RNS) announcement about a PDMR Dealing (person dealing in the company's shares). The document itself is short (2891 characters) and mainly serves to furnish the RNS announcement as an exhibit. It does not contain financial statements, detailed management discussion, or other substantive report content. It is primarily a regulatory filing to disclose insider dealing information. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and does not qualify as a Director's Dealing (DIRS) because it is furnishing an RNS announcement rather than a direct insider transaction report form. The document is not an announcement of a report publication (RPA) because it is itself a filing. Hence, the classification is RNS with high confidence.
2020-12-10 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It references an attached Regulatory News Service (RNS) announcement dated December 1, 2020, about an Investor Update Call. The document length is only 2930 characters, which is quite short and primarily serves to furnish the RNS announcement rather than containing substantive financial data or detailed report content. The text explicitly states that the attached RNS announcement is being furnished and is not deemed "filed" for certain regulatory purposes. There is no detailed financial data, management discussion, or full report content present. According to the "Menu vs Meal" rule, this is an announcement of a report (the RNS announcement) rather than the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories and includes such announcements and compliance documents.
2020-12-01 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It references an attached Regulatory News Service (RNS) announcement about PDMR Dealing (person dealing in the company's shares). The document itself is short (2886 characters) and primarily serves to furnish the RNS announcement rather than provide detailed financial data or a full report. It includes a signature page and an exhibit index pointing to the RNS announcement. There is no substantive financial data, management discussion, or detailed report content. According to the rules, such a document is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories and for filings like Form 6-K that provide regulatory announcements without full reports.
2020-11-18 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It contains a Regulatory News Service (RNS) announcement about a collaboration for a clinical trial. The document explicitly states that the RNS announcement is furnished as an exhibit and is not considered filed for certain regulatory purposes. The document length is 2982 characters, which is relatively short and mainly serves to provide the RNS announcement. There are no financial statements or detailed financial data present. The content is primarily an announcement of a regulatory news release rather than a full report or detailed financial disclosure. According to the rules, short documents that announce or furnish reports without containing the full report themselves should be classified as Regulatory Filings (RNS).
2020-11-12 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It contains a regulatory news service announcement about the initiation of a clinical trial. The document is relatively short (3017 characters) and primarily furnishes an announcement rather than detailed financial data or comprehensive reporting. It does not contain financial statements or detailed management discussion. The content is an announcement of a regulatory news service release, not a full report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-11-02 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.